AAAAAA
Results: 1-25/33
Authors:
AGUNDEZ JAG
GALLARDO L
MARTINEZ C
GERVASINI G
BENITEZ J
Citation: Jag. Agundez et al., MODULATION OF CYP1A2 ENZYME-ACTIVITY BY INDOLEAMINES - INHIBITION BY SEROTONIN AND TRYPTAMINE, Pharmacogenetics, 8(3), 1998, pp. 251-258
Authors:
CARRILLO JA
RAMOS SI
AGUNDEZ JAG
MARTINEZ C
BENITEZ J
Citation: Ja. Carrillo et al., ANALYSIS OF MIDAZOLAM AND METABOLITES IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY - PROBE OF CYP3A, Therapeutic drug monitoring, 20(3), 1998, pp. 319-324
Authors:
MARTINEZ C
AGUNDEZ JAG
OLIVERA M
LLERENA A
RAMIREZ R
HERNANDEZ M
BENITEZ J
Citation: C. Martinez et al., INFLUENCE OF GENETIC ADMIXTURE ON POLYMORPHISMS OF DRUG-METABOLIZING-ENZYMES - ANALYSES OF MUTATIONS ON NAT2 AND CYP2E1 GENES IN A MIXED HISPANIC POPULATION, Clinical pharmacology and therapeutics, 63(6), 1998, pp. 623-628
Authors:
AGUNDEZ JAG
MARTINEZ C
OLIVERA M
GALLARDO L
LADERO JM
ROSADO C
PRADOS J
RODRIGUEZMOLINA J
RESEL L
BENITEZ J
Citation: Jag. Agundez et al., EXPRESSION IN HUMAN PROSTATE OF DRUG-METABOLIZING AND CARCINOGEN-METABOLIZING ENZYMES - ASSOCIATION WITH PROSTATE-CANCER RISK, British Journal of Cancer, 78(10), 1998, pp. 1361-1367
Authors:
AGUNDEZ JAG
RAMIREZ R
HERNANDEZ M
LLERENA A
BENITEZ J
Citation: Jag. Agundez et al., MOLECULAR HETEROGENEITY AT THE CYP2D GENE LOCUS IN NICARAGUANS - IMPACT OF GENE-FLOW FROM EUROPE, Pharmacogenetics, 7(4), 1997, pp. 337-340
Authors:
GULLSTEN H
AGUNDEZ JAG
BENITEZ J
LAARA E
LADERO JM
DIAZRUBIO M
FERNANDEZSALGUERO P
GONZALEZ F
RAUTIO A
PELKONEN O
RAUNIO H
Citation: H. Gullsten et al., CYP2A6 GENE POLYMORPHISM AND RISK OF LIVER-CANCER AND CIRRHOSIS, Pharmacogenetics, 7(3), 1997, pp. 247-250
Authors:
MARTINEZ C
AGUNDEZ JAG
GERVASINI G
MARTIN R
BENITEZ J
Citation: C. Martinez et al., TRYPTAMINE - A POSSIBLE ENDOGENOUS SUBSTRATE FOR CYP2D6, Pharmacogenetics, 7(2), 1997, pp. 85-93
Authors:
MARTINEZ C
AGUNDEZ JAG
GERVASINI G
MARTIN R
BENITEZ J
Citation: C. Martinez et al., TRYPTAMINE - A POSSIBLE ENDOGENOUS SUBSTRATE FOR CYP2D6, Pharmacogenetics, 7(2), 1997, pp. 85-93
Authors:
AGUNDEZ JAG
JIMENEZJIMENEZ FJ
TEJEDA R
LEDESMA MC
ORTIPAREJA M
GASALLA T
MOLINA JA
RUIZ J
CORIA F
DUARTE J
VAZQUEZ A
LADERO JM
BENITEZ J
Citation: Jag. Agundez et al., CYP2D6 POLYMORPHISM IS NOT ASSOCIATED WITH ESSENTIAL TREMOR, European neurology, 38(2), 1997, pp. 99-104
Authors:
JAIME MTE
PENCO JMM
AGUNDEZ JAG
LOSCOS MJC
RODRIGUEZ SS
MARTINEZ FB
DETEJADA RG
ALVAREZ EL
RODRIGUEZ JB
Citation: Mte. Jaime et al., URINARY-BLADDER CANCER IN A GIRL WITH A SLOW-ACETYLATOR GENOTYPE AND TREATED WITH SULFASALAZINE, British Journal of Urology, 80(1), 1997, pp. 151-152
Authors:
AGUNDEZ JAG
RODRIGUEZ I
OLIVERA M
LADERO JM
GARCIA MA
RIBERA JM
BENITEZ J
Citation: Jag. Agundez et al., CYP2D6, NAT2 AND CYP2E1 GENETIC POLYMORPHISMS IN NONAGENARIANS, Age and ageing, 26(2), 1997, pp. 147-151
Authors:
AGUNDEZ JAG
OLIVERA M
LADERO JM
RODRIGUEZLESCURE A
LEDESMA MC
DIAZRUBIO M
MEYER UA
BENITEZ J
Citation: Jag. Agundez et al., INCREASED RISK FOR HEPATOCELLULAR-CARCINOMA IN NAT2-SLOW ACETYLATORS AND CYP2D6-RAPID METABOLIZERS, Pharmacogenetics, 6(6), 1996, pp. 501-512
Authors:
AGUNDEZ JAG
OLIVERA M
MARTINEZ C
LADERO JM
BENITEZ J
Citation: Jag. Agundez et al., IDENTIFICATION AND PREVALENCE STUDY OF 17 ALLELIC VARIANTS OF THE HUMAN NAT2 GENE IN A WHITE-POPULATION, Pharmacogenetics, 6(5), 1996, pp. 423-428
Authors:
AGUNDEZ JAG
MENAYA JG
TEJEDA R
LAGO F
CHAVEZ M
BENITEZ J
Citation: Jag. Agundez et al., GENETIC-ANALYSIS OF THE NAT2 AND CYP2D6 POLYMORPHISMS IN WHITE PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS, Pharmacogenetics, 6(5), 1996, pp. 465-472
Authors:
LADONA MG
ABILDUA RE
LADERO JM
ROMAN JM
PLAZA MA
AGUNDEZ JAG
MUNOZ JJ
BENITEZ J
Citation: Mg. Ladona et al., CYP2D6 GENOTYPES IN SPANISH WOMEN WITH BREAST-CANCER, Cancer letters, 99(1), 1996, pp. 23-28
Authors:
AGUNDEZ JAG
BENITEZ J
Citation: Jag. Agundez et J. Benitez, DETERMINATION OF AMINOPYRINE AND DIPYRONE METABOLITES IN URINE, Therapeutic drug monitoring, 18(1), 1996, pp. 104-107
Authors:
LADERO JM
AGUNDEZ JAG
RODRIGUEZLESCURE A
DIAZRUBIO M
BENITEZ J
Citation: Jm. Ladero et al., RSAI POLYMORPHISM AT THE CYTOCHROME P4502E1 LOCUS AND RISK OF HEPATOCELLULAR-CARCINOMA, Gut, 39(2), 1996, pp. 330-333
Authors:
BENITEZ J
MARTINEZ C
AGUNDEZ JAG
RAMOS S
Citation: J. Benitez et al., TRYPTAMINE - A POTENTIAL ENDOGENOUS SUBSTRATE OF CYP2D6, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 20-20
Authors:
BENITEZ J
AGUNDEZ JAG
LADERO JM
RODRIGUEZLESCURE A
DIAZRUBIO M
Citation: J. Benitez et al., RSAI POLYMORPHISM AT THE CYP2E1 LOCUS AND RISK OF PRIMARY LIVER-CANCER, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 21-21
Authors:
MARTINEZ C
AGUNDEZ JAG
OLIVERA M
MARTIN R
LADERO JM
BENITEZ J
Citation: C. Martinez et al., LUNG-CANCER AND MUTATIONS AT THE POLYMORPHIC NAT2 GENE LOCUS, Pharmacogenetics, 5(4), 1995, pp. 207-214
Authors:
AGUNDEZ JAG
CARRILLO JA
MARTINEZ C
BENITEZ J
Citation: Jag. Agundez et al., AMINOPYRINE METABOLISM IN MAN - THE ACETYLATION OF AMINOANTIPYRINE COSEGREGATES WITH ACETYLATION OF CAFFEINE, Therapeutic drug monitoring, 17(1), 1995, pp. 1-5
Authors:
AGUNDEZ JAG
LEDESMA MC
BENITEZ J
LADERO JM
RODRIGUEZLESCURE A
DIAZRUBIO E
DIAZRUBIO M
Citation: Jag. Agundez et al., CYP2D6 GENES AND RISK OF LIVER-CANCER, Lancet, 345(8953), 1995, pp. 830-831
Authors:
AGUNDEZ JAG
MARTINEZ C
BENITEZ J
Citation: Jag. Agundez et al., METABOLISM OF AMINOPYRINE AND DERIVATIVES IN MAN - IN-VIVO STUDY OF MONOMORPHIC AND POLYMORPHIC METABOLIC PATHWAYS, Xenobiotica, 25(4), 1995, pp. 417-427
Authors:
AGUNDEZ JAG
LADERO JM
OLIVERA M
ABILDUA R
ROMAN JM
BENITEZ J
Citation: Jag. Agundez et al., GENETIC-ANALYSIS OF THE ARYLAMINE N-ACETYLTRANSFERASE POLYMORPHISM INBREAST-CANCER PATIENTS, Oncology, 52(1), 1995, pp. 7-11
Authors:
AGUNDEZ JAG
LEDESMA MC
LADERO JM
BENITEZ J
Citation: Jag. Agundez et al., PREVALENCE OF CYP2D6 GENE DUPLICATION AND ITS REPERCUSSION ON THE OXIDATIVE PHENOTYPE IN A WHITE-POPULATION, Clinical pharmacology and therapeutics, 57(3), 1995, pp. 265-269